Qorvo (QRVO) 10-Q 29 Jan 25 2025 Q3 Quarterly report Financial data

Cover Page

Cover Page - shares	9 Months Ended
	Dec. 28, 2024	Jan. 22, 2025
Cover [Abstract]
Document Transition Report	false
Document Quarterly Report	true
Title of 12(b) Security	Common Stock, $0.0001 par value
Entity Current Reporting Status	Yes
Entity Incorporation, State or Country Code	DE
Entity Registrant Name	Qorvo, Inc.
City Area Code	336
Entity Central Index Key	0001604778
Document Type	10-Q
Document Period End Date	Dec. 28, 2024
Entity File Number	001-36801
Amendment Flag	false
Document Fiscal Period Focus	Q3
Current Fiscal Year End Date	--03-29
Entity Filer Category	Large Accelerated Filer
Entity Emerging Growth Company	false
Entity Small Business	false
Entity Common Stock, Shares Outstanding		93,396,832
Entity Address, Address Line One	7628 Thorndike Road
Local Phone Number	664-1233
Entity Interactive Data Current	Yes
Entity Shell Company	false
Trading Symbol	QRVO
Security Exchange Name	NASDAQ
Entity Tax Identification Number	46-5288992
Entity Address, City or Town	Greensboro,
Entity Address, State or Province	NC
Entity Address, Postal Zip Code	27409-9421
Document Fiscal Year Focus	2025

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Dec. 28, 2024	Mar. 30, 2024
Current assets:
Cash and cash equivalents	$ 769,432	$ 1,029,258
Accounts receivable, net of allowances of $313 as of December 28, 2024 and March 30, 2024	427,863	412,960
Inventories	656,216	710,555
Prepaid expenses	38,368	40,563
Other Receivables, Net, Current	10,859	14,427
Other current assets	77,690	78,993
Disposal Group, Including Discontinued Operation, Assets	116,435	159,278
Total current assets	2,096,863	2,446,034
Property and equipment, net of accumulated depreciation of $1,806,645 and $1,683,592 as of December 28, 2024 and March 30, 2024, respectively	820,874	870,982
Goodwill	2,437,234	2,534,601
Intangible assets, net	332,338	509,383
Long-term investments	25,692	23,252
Other non-current assets	250,095	170,383
Total assets	5,963,096	6,554,635
Current liabilities:
Accounts payable	283,341	252,993
Accrued liabilities	268,335	336,767
Long-term Debt, Current Maturities	0	438,740
Other current liabilities	227,110	113,215
Disposal Group, Including Discontinued Operation, Liabilities	29,075	88,372
Total current liabilities	807,861	1,230,087
Long-Term Debt, Excluding Current Maturities	1,549,230	1,549,272
Other long-term liabilities	225,572	218,904
Total liabilities	2,582,663	2,998,263
Stockholders’ equity:
Preferred stock, $.0001 par value; 5,000 shares authorized; no shares issued and outstanding	0	0
Common stock and additional paid-in capital, $.0001 par value; 405,000 shares authorized; 93,559 and 95,798 shares issued and outstanding at December 28, 2024 and March 30, 2024, respectively	3,455,850	3,651,067
Accumulated other comprehensive loss	(10,069)	(5,097)
Accumulated deficit	(65,348)	(89,598)
Total stockholders’ equity	3,380,433	3,556,372
Total liabilities and stockholders’ equity	$ 5,963,096	$ 6,554,635

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($) $ in Thousands	Dec. 28, 2024	Mar. 30, 2024
Statement of Financial Position [Abstract]
Common stock, shares outstanding	93,559,000	95,798,000
Accounts Receivable, Allowance for Credit Loss, Current	$ 313	$ 313
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	$ 1,806,645	$ 1,683,592
Preferred Stock, par value	$ 0.0001	$ 0.0001
Preferred Stock, Shares Authorized	5,000,000	5,000,000
Preferred Stock, Shares Issued	0	0
Preferred Stock, Shares Outstanding	0	0
Common Stock, par value	$ 0.0001	$ 0.0001
Common Stock, Shares Authorized	405,000,000	405,000,000
Common Stock, Shares, Issued	93,559,000	95,798,000

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 28, 2024	Dec. 30, 2023	Dec. 28, 2024	Dec. 30, 2023
Income Statement [Abstract]
Revenues	$ 916,317	$ 1,073,861	$ 2,849,497	$ 2,828,518
Cost of goods sold	524,901	685,983	1,680,471	1,721,880
Gross profit	391,416	387,878	1,169,026	1,106,638
Operating Expenses [Abstract]
Research and Development Expense	179,126	164,329	567,778	502,366
Selling, general and administrative	90,360	86,914	313,043	296,033
Goodwill, Impairment Loss	0	173,414	96,458	221,414
Other operating expense	68,905	4,790	124,441	25,102
Total operating expenses	338,391	429,447	1,101,720	1,044,915
Operating Income (Loss), Total	53,025	(41,569)	67,306	61,723
Interest expense	(18,655)	(17,581)	(58,343)	(51,963)
Other income, net	14,526	15,359	41,713	34,286
Income before income taxes	48,896	(43,791)	50,676	44,046
Income tax benefit	(7,625)	(83,147)	(26,426)	(117,103)
Net income	$ 41,271	$ (126,938)	$ 24,250	$ (73,057)
Earnings Per Share [Abstract]
Basic	$ 0.44	$ (1.31)	$ 0.26	$ (0.75)
Diluted	$ 0.43	$ (1.31)	$ 0.25	$ (0.75)
Weighted Average Number of Shares Outstanding, Diluted [Abstract]
Basic	94,341	97,152	94,942	97,905
Diluted	95,031	97,152	95,808	97,905

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 28, 2024	Dec. 30, 2023	Dec. 28, 2024	Dec. 30, 2023
Statement of Comprehensive Income [Abstract]
Numerator for basic and diluted net income (loss) per share — net income (loss) available to common stockholders	$ 41,271	$ (126,938)	$ 24,250	$ (73,057)
Other comprehensive (loss) income, net of tax:
Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment, after Tax	1	0	(229)	0
Foreign currency translation adjustment, including intra-entity foreign currency transactions that are of a long-term investment nature	(11,218)	13,714	(4,742)	3,286
Reclassification adjustments, net of tax:
Amortization of pension actuarial gain	0	(3)	(1)	(9)
Other comprehensive (loss) income	(11,217)	13,711	(4,972)	3,277
Total comprehensive income (loss)	$ 30,054	$ (113,227)	$ 19,278	$ (69,780)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Accumulated Other Comprehensive Loss	Retained Earnings [Member]
Common Stock, Shares, Outstanding		98,649
Common stock and additional paid-in capital	$ 3,821,474
Stockholders' Equity Attributable to Parent	3,902,794
Accumulated Other Comprehensive Income (Loss), Net of Tax	(3,175)
Retained Earnings (Accumulated Deficit)	84,495
Net income (loss)	(73,057)	$ 0	$ 0	$ (73,057)
Other Comprehensive Income (Loss), Net of Tax	3,277	$ 0	3,277	0
Exercise Of Stock Options And Vesting Of Restricted Stock Units Net Of Shares Withheld For Employee Taxes Shares		616
Exercise Of Stock Options And Vesting Of Restricted Stock Units Net Of Shares Withheld For Employee Taxes	(25,010)	$ (25,010)	0	0
Stock Issued During Period, Shares, Employee Stock Purchase Plans		479
Stock Issued During Period, Value, Employee Stock Purchase Plan	$ 35,045	$ 35,045	0	0
Stock Repurchased During Period, Shares	(3,100)	(3,064)
Stock Repurchased During Period, Value	$ (301,978)	$ (198,208)	0	(103,770)
Stock-based compensation	97,276	$ 97,276	0	0
Common Stock, Shares, Outstanding		97,506
Common stock and additional paid-in capital	3,796,189
Stockholders' Equity Attributable to Parent	3,817,186
Accumulated Other Comprehensive Income (Loss), Net of Tax	(13,609)
Retained Earnings (Accumulated Deficit)	34,606
Net income (loss)	(126,938)	$ 0	0	(126,938)
Other Comprehensive Income (Loss), Net of Tax	13,711	$ 0	13,711	0
Exercise Of Stock Options And Vesting Of Restricted Stock Units Net Of Shares Withheld For Employee Taxes Shares		19
Exercise Of Stock Options And Vesting Of Restricted Stock Units Net Of Shares Withheld For Employee Taxes	(847)	$ (847)	0	0
Stock Issued During Period, Shares, Employee Stock Purchase Plans		217
Stock Issued During Period, Value, Employee Stock Purchase Plan	$ 15,865	$ 15,865	0	0
Stock Repurchased During Period, Shares	(1,100)	(1,062)
Stock Repurchased During Period, Value	$ (100,812)	$ (100,812)	0	0
Stock-based compensation	20,182	$ 20,182	0	0
Common Stock, Shares, Outstanding		96,680
Common stock and additional paid-in capital	3,730,577
Stockholders' Equity Attributable to Parent	3,638,347
Accumulated Other Comprehensive Income (Loss), Net of Tax	102
Retained Earnings (Accumulated Deficit)	$ (92,332)
Common Stock, Shares, Outstanding	95,798
Common stock and additional paid-in capital	$ 3,651,067
Stockholders' Equity Attributable to Parent	3,556,372
Accumulated Other Comprehensive Income (Loss), Net of Tax	(5,097)
Retained Earnings (Accumulated Deficit)	(89,598)
Net income (loss)	24,250	$ 0	0	24,250
Other Comprehensive Income (Loss), Net of Tax	(4,972)	$ 0	(4,972)	0
Exercise Of Stock Options And Vesting Of Restricted Stock Units Net Of Shares Withheld For Employee Taxes Shares		605
Exercise Of Stock Options And Vesting Of Restricted Stock Units Net Of Shares Withheld For Employee Taxes	(30,515)	$ (30,515)	0	0
Stock Issued During Period, Shares, Employee Stock Purchase Plans		499
Stock Issued During Period, Value, Employee Stock Purchase Plan	$ 34,233	$ 34,233	0	0
Stock Repurchased During Period, Shares	(3,300)	(3,343)
Stock Repurchased During Period, Value	$ (308,296)	$ (308,296)	0	0
Stock-based compensation	109,361	$ 109,361	0	0
Common Stock, Shares, Outstanding		94,664
Common stock and additional paid-in capital	3,515,640
Stockholders' Equity Attributable to Parent	3,410,169
Accumulated Other Comprehensive Income (Loss), Net of Tax	1,148
Retained Earnings (Accumulated Deficit)	(106,619)
Net income (loss)	41,271	$ 0	0	41,271
Other Comprehensive Income (Loss), Net of Tax	(11,217)	$ 0	(11,217)	0
Exercise Of Stock Options And Vesting Of Restricted Stock Units Net Of Shares Withheld For Employee Taxes Shares		28
Exercise Of Stock Options And Vesting Of Restricted Stock Units Net Of Shares Withheld For Employee Taxes	(994)	$ (994)	0	0
Stock Issued During Period, Shares, Employee Stock Purchase Plans		233
Stock Issued During Period, Value, Employee Stock Purchase Plan	$ 14,446	$ 14,446	0	0
Stock Repurchased During Period, Shares	(1,400)	(1,366)
Stock Repurchased During Period, Value	$ (100,825)	$ (100,825)	0	0
Stock-based compensation	$ 27,583	$ 27,583	$ 0	$ 0
Common Stock, Shares, Outstanding	93,559	93,559
Common stock and additional paid-in capital	$ 3,455,850
Stockholders' Equity Attributable to Parent	3,380,433
Accumulated Other Comprehensive Income (Loss), Net of Tax	(10,069)
Retained Earnings (Accumulated Deficit)	$ (65,348)

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Dec. 28, 2024	Dec. 30, 2023
Cash flows from operating activities:
Net income (loss)	$ 24,250	$ (73,057)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation	122,912	146,841
Intangible assets amortization	103,146	92,308
Deferred income taxes	(63,268)	62,365
Goodwill, Impairment Loss	96,458	221,414
Stock-based compensation expense	108,931	99,253
Other, net	73,588	24,453
Changes in operating assets and liabilities:
Accounts receivable, net	(16,449)	(179,315)
Inventories	3,819	66,190
Prepaid expenses and other assets	(30,510)	(10,312)
Accounts payable and accrued liabilities	(17,621)	183,091
Income taxes payable and receivable	(11,758)	(9,408)
Other liabilities	29,521	7,022
Net cash provided by operating activities	423,019	630,845
Cash flows from investing activities:
Purchase of property and equipment	(109,087)	(94,514)
Proceeds from Sale of Property, Plant, and Equipment	2,396	47,446
Proceeds from Divestiture of Businesses	55,576	0
Other investing activities	(7,969)	23,777
Net cash used in investing activities	(59,084)	(23,291)
Cash flows from financing activities:
Repurchase of common stock, including transaction costs	(306,355)	(300,043)
Proceeds from the issuance of common stock	24,405	26,358
Tax withholding paid on behalf of employees for restricted stock units	(30,545)	(26,318)
Repayments of Debt	439,124	17,914
Purchase and supply commitment, Supplies Proceeds	129,307	0
Other financing activities	(18,629)	(9,933)
Net cash used in financing activities	(640,941)	(327,850)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(2,820)	3,340
Net (decrease) increase in cash, cash equivalents and restricted cash	(279,826)	283,044
Cash, cash equivalents and restricted cash at the beginning of the period	1,049,258	808,943
Cash, cash equivalents and restricted cash at the end of the period	769,432	1,091,987
Cash and Cash Equivalents, at Carrying Value	769,432	1,071,987
Restricted Cash	0	20,000
Capital expenditures included in liabilities	$ 63,104	$ 77,704

Basis of Presentation and Signi

Basis of Presentation and Significant Accounting Policies	9 Months Ended
	Dec. 28, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES	1. BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES The accompanying Condensed Consolidated Financial Statements of Qorvo, Inc. and Subsidiaries (together, the "Company" or "Qorvo") have been prepared in conformity with accounting principles generally accepted in the United States ("U.S. GAAP"). The preparation of these financial statements requires management to make estimates and assumptions, which could differ materially from actual results. In addition, certain information or footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed, or omitted, pursuant to the rules and regulations of the SEC. In the opinion of management, the financial statements include all adjustments (which are of a normal and recurring nature) necessary for the fair presentation of the results of the interim periods presented. These Condensed Consolidated Financial Statements should be read in conjunction with the Company's audited consolidated financial statements and notes thereto included in Qorvo’s Annual Report on Form 10-K for the fiscal year ended March 30, 2024. The Condensed Consolidated Financial Statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. The Company is organized into three operating and reportable segments that align technologies and applications with customers and end markets: High Performance Analog ("HPA"), Connectivity and Sensors Group ("CSG") and Advanced Cellular Group ("ACG"). Certain prior period amounts have been reclassified to conform to the fiscal 2025 presentation. The Company uses a 52- or 53-week fiscal year ending on the Saturday closest to March 31 of each year. Each fiscal year, the first quarter ends on the Saturday closest to June 30, the second quarter ends on the Saturday closest to September 30 and the third quarter ends on the Saturday closest to December 31. Fiscal years 2025 and 2024 are 52-week years.

Recent Accounting Pronouncement

Recent Accounting Pronouncements	9 Months Ended
	Dec. 28, 2024
Accounting Standards Update and Change in Accounting Principle [Abstract]
Accounting Standards Update and Change in Accounting Principle [Text Block]	2. RECENT ACCOUNTING PRONOUNCEMENTS AND OTHER DEVELOPMENTS In August 2022, the Creating Helpful Incentives to Produce Semiconductors and Science Act (the "CHIPS Act") was signed into law. The CHIPS Act provides for a 25% refundable tax credit on certain investments in domestic semiconductor manufacturing. The tax credit is provided for qualifying property and equipment which is placed in service after December 31, 2022, and for which construction begins before January 1, 2027. The CHIPS Act also provides for certain other financial incentives to further investments in domestic semiconductor manufacturing. During the three and nine months ended December 28, 2024, the Company recognized an anticipated tax credit within other non-current assets related to qualifying expenditures placed in service since December 31, 2022 (which will be amortized over the useful lives of the qualifying assets), with a corresponding reduction to the carrying amount of the qualifying property and equipment. In November 2023, the Financial Accounting Standards Board issued Accounting Standards Update 2023-07, " Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures " ("ASU 2023-07"), which requires enhanced disclosures related to significant segment expenses. The Company will adopt ASU 2023-07 for its fiscal 2025 annual report and for interim periods beginning in fiscal 2026 on a retrospective basis. The Company is currently evaluating the effect this new standard will have on its disclosures.

Inventories

Inventories	9 Months Ended
	Dec. 28, 2024
Inventory Disclosure [Abstract]
INVENTORIES	3. INVENTORIES The components of inventories, net of reserves, are as follows (in thousands): December 28, 2024 (1) March 30, 2024 Raw materials $ 202,661 $ 201,748 Work in process 311,046 347,175 Finished goods 142,509 161,632 Total inventories $ 656,216 $ 710,555 (1) Excludes $35.3 million of inventories, net of reserves, which has been reclassified to "Assets of disposal group held for sale." Refer to Note 5 for additional information.

Business Divestiture

Business Divestiture	9 Months Ended
	Dec. 28, 2024
Discontinued Operations and Disposal Groups [Abstract]
Mergers, Acquisitions and Dispositions Disclosures	4. BUSINESS DIVESTITURE On December 16, 2023, the Company entered into a definitive agreement (the "Purchase Agreement") with Luxshare Precision Industry Co., Ltd. ("Luxshare") to divest its assembly and test operations in Beijing and Dezhou, China (the "China Disposal Group") for preliminary cash proceeds of approximately $240.0 million (for the cash on hand of the disposed business, the assets and liabilities of the China Disposal Group and inventory). In the fourth quarter of fiscal 2024, regulatory approvals were received, and the China Disposal Group met the criteria to be classified as held for sale in accordance with Accounting Standards Codification ("ASC") 360, "Property, Plant and Equipment" ("ASC 360"). In accordance with ASC 805, " Business Combinations, " the China Disposal Group constituted a business, and therefore, the Company allocated $22.0 million of goodwill from three of its reporting units to assets held for sale based on a relative fair value basis. These reporting units were evaluated for impairment subsequent to the allocation of goodwill to the China Disposal Group and it was determined that the fair value of all reporting units was in excess of their carrying amounts. Additionally, in accordance with ASC 360, the China Disposal Group was measured at the lower of carrying value or fair value less costs to sell. As the carrying value of the China Disposal Group exceeded the fair value less costs to sell, a loss of $35.3 million was recognized for the fiscal year ended March 30, 2024, which was recorded in "Other operating expense" in the Consolidated Statement of Operations. The divestiture of the China Disposal Group did not meet the criteria to be reported as discontinued operations per ASC 205-20, " Presentation of Financial Statements: Discontinued Operations " ("ASC 205-20"). The Company completed the sale of its assembly and test operations in China on May 2, 2024 for a purchase price of approximately $232.0 million, resulting in an incremental loss of $8.0 million (which included an ad ditional goodwill write-off of $1.0 million) recorded in "Other operating expense" in the Condensed Consolidated Statement of Operations for the three months ended June 29, 2024 . The consideration received was for the cash on hand of the disposed business of $29.0 million , the assets and liabilities of the China Disposal Group of $76.0 million and inventory of $127.0 million . The inventory amount relates to inventory that the Company sold to Luxshare and is obligated to repurchase at a future date subsequent to the performance of assembly and test services by Luxshare pursuant to a supply agreement. The purchase price, which was subject to certain post-closing adjustments, increased to $234.0 million in the three months ended September 28, 2024 , as a result of a $2.0 million increase in the value of inventory. Under the ongoing supply agreement, legal title to the inventory sold by the Company resides with Luxshare. In accordance with ASC 606 " Revenue from Contracts with Customers ," the Company will continue to recognize the inventory on its balance sheet and record a financial liability (which is included in "Other current liabilities") equal to the cash received by the Company attributable to the inventory subject to repurchase. The cash received from the sale of the assets and liabilities of the China Disposal Group of $76.0 million is included in cash flows from investing activities in the Condensed Consolidated Statement of Cash Flows for the nine months ended December 28, 2024, net of a $20.0 million deposit received in fiscal 2024 upon execution of the Purchase Agreement (which was included in “Other investing activities” in the fiscal 2024 Consolidated Statement of Cash Flows). The net proceeds from the sale of inventory subject to repurchase by the Company is included in cash flows from financing activities in the Condensed Consolidated Statement of Cash Flows for the nine months ended December 28, 2024.

Business Held For Sale - Dispos

Business Held For Sale - Disposal Groups	9 Months Ended
	Dec. 28, 2024
Discontinued Operations and Disposal Groups [Abstract]
Disposal Groups, Including Discontinued Operations, Disclosure	5. BUSINESS HELD FOR SALE In the second quarter of fiscal 2025, the Company determined that there was a more-likely-than-not expectation of divesting its silicon carbide ("SiC") power device business and impairment testing was triggered. The inventory and long-lived assets that were held and used by this business were reviewed for impairment in accordance with ASC 330 , "Inventory" and ASC 360, respectively, resulting in inventory write-downs of $13.7 million (for inventory expected to be disposed of) and impairments of intangible assets (primarily developed technology) of $16.6 million. In addition, as the SiC power device business constituted a reporting unit, the goodwill of the reporting unit was also subject to an impairment assessment in accordance with ASC 350, "Intangibles - Goodwill and Other" and it was determined that the carrying value exceeded the fair value of this reporting unit, resulting in a goodwill impairment charge of approximately $96.5 million (representing the entire goodwill assigned to this reporting unit). Subsequently, in December 2024, the Company entered into a definitive agreement to divest its SiC power device business (the "SiC Disposal Group") for cash proceeds of approximately $115.0 million. As of December 28, 2024, the SiC Disposal Group met the criteria to be classified as held for sale in accordance with ASC 360. The divestiture of the SiC Disposal Group did not meet the criteria to be reported as discontinued operations per ASC 205-20. In accordance with ASC 360, the SiC Disposal Group was measured at the lower of carrying value or fair value (based on the preliminary purchase price) less costs to sell. As the fair value less costs to sell exceeded the carrying value of the SiC Disposal Group, no loss was recognized upon classification of the SiC Disposal Group as held for sale. The carrying values of the major classes of assets and liabilities classified as held for sale as of December 28, 2024 are as follows (in thousands): Intangible assets, net $ 74,034 Inventories 35,317 Other assets 7,084 Total assets of disposal group held for sale $ 116,435 Accounts payable and accrued liabilities $ 14,008 Deferred tax liabilities 13,407 Other liabilities 1,660 Total liabilities of disposal group held for sale $ 29,075 On January 14, 2025, the Company completed the sale of its SiC power device business, and based on the purchase price, the Company expects to record a gain on the sale in the fourth quarter of fiscal 2025. Refer to Note 6 for additional information regarding the impairment of goodwill and intangible assets in the second quarter of fiscal 2025 and refer to Note 12 for information regarding additional charges associated with the divestiture of the SiC power device business.

Goodwill and Intangible Assets

Goodwill and Intangible Assets	9 Months Ended
	Dec. 28, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets Disclosure [Text Block]	6. GOODWILL AND INTANGIBLE ASSETS In the second quarter of fiscal 2025, the Company determined that there was a more-likely-than-not expectation of divesting its SiC power device business, and impairment testing was triggered. The impairment testing resulted in impairments of goodwill and intangible assets (primarily developed technology) of approximately $96.5 million and $16.6 million, respectively . The estimated fair values of the intangible assets and the reporting unit were determined using a market approach, and the significant inputs related to valuing these assets are classified as Level 3 in the fair value hierarchy. In December 2024, the Company entered into a definitive agreement to divest its SiC power device business and, as a result, the SiC Disposal Group met the criteria to be classified as held for sale as of December 28, 2024 in accordance with ASC 360 (refer to Note 5 for additional information). The changes in the carrying amount of goodwill are as follows (in thousands): HPA CSG ACG Total Balance as of March 30, 2024 (1) $ 517,542 $ 300,299 $ 1,716,760 $ 2,534,601 Goodwill impairment (96,458) — — (96,458) Goodwill written off related to sale of business (2) — (200) (800) (1,000) Anokiwave, Inc. measurement period adjustments 91 — — 91 Balance as of December 28, 2024 (1) $ 421,175 $ 300,099 $ 1,715,960 $ 2,437,234 (1) The Company’s goodwill balance is presented net of accumulated impairment losses totaling $999.9 million and $903.4 million as of December 28, 2024 and March 30, 2024, respectively, which were recognized in fiscal years 2009, 2013, 2014, 2022, 2023, 2024 and 2025. (2) Refer to Note 4 for additional information. The following table summarizes information regarding the gross carrying amounts and accumulated amortization of intangible assets (in thousands): December 28, 2024 March 30, 2024 Gross Accumulated Gross Accumulated Developed technology (1) $ 690,472 $ 440,322 $ 903,089 $ 484,347 Customer relationships (1) 80,800 59,813 100,040 67,999 Technology licenses 74,519 23,388 54,869 6,525 Trade names 700 204 1,610 939 In-process research and development 9,574 N/A 9,585 N/A Total (2) $ 856,065 $ 523,727 $ 1,069,193 $ 559,810 (1) The December 28, 2024 balances exclude $109.5 million of gross carrying amount and $35.5 million of accumulated amortization for Developed technology, as well as $19.2 million of both gross carrying amount and accumulated amortization for Customer relationships of the SiC Disposal Group which has been reclassified to "Assets of disposal group held for sale." Refer to Note 5 for additional information. (2) Amounts include the impact of foreign currency translation. At the beginning of each fiscal year, the Company removes the gross asset and accumulated amortization amounts of intangible assets that have reached the end of their useful lives and have been fully amortized. Useful lives are estimated based on the expected economic benefit to be derived from the intangible assets.

Investments and Fair Value of F

Investments and Fair Value of Financial Instruments	9 Months Ended
	Dec. 28, 2024
Investments and Fair Value Measurements [Abstract]
Investments and Fair Value Measurements [Text Block]	7. INVESTMENTS AND FAIR VALUE MEASUREMENTS Invested funds under the Company's non-qualified deferred compensation plan are held in a rabbi trust and consist of mutual funds. The fair value of the mutual funds is calculated using the net asset value per share determined by quoted active market prices of the underlying investments and are considered Level 1 in the fair value hierarchy. The fair value of the mutual funds as of December 28, 2024 and March 30, 2024 was $61.7 million and $52.3 million

Long-Term Debt

Long-Term Debt	9 Months Ended
	Dec. 28, 2024
Debt Disclosure [Abstract]
DEBT	8. DEBT The following table summarizes the Company's outstanding debt (in thousands): December 28, 2024 March 30, 2024 1.750% senior notes due 2024 $ — $ 439,738 4.375% senior notes due 2029 850,000 850,000 3.375% senior notes due 2031 700,000 700,000 Unamortized premium, discount and issuance costs, net (770) (1,726) Total debt 1,549,230 1,988,012 Less current portion of debt — (438,740) Total long-term debt $ 1,549,230 $ 1,549,272 Credit Agreement On April 23, 2024, the Company entered into a five-year unsecured senior credit facility pursuant to a credit agreement with Bank of America, N.A., as administrative agent, swing line lender and letter of credit issuer and a syndicate of lenders (the "Credit Agreement"), which replaced the previous credit agreement dated as of September 29, 2020. The Credit Agreement provides for a $325.0 million senior revolving line of credit (the "Revolving Facility"). Up to $25.0 million of the Revolving Facility may be used for the issuance of standby letters of credit, and up to $10.0 million of the Revolving Facility may be used for swing line advances (i.e., short-term borrowings made available from the lead lender). The Company may request at any time that the Revolving Facility be increased by up to $325.0 million , subject to securing additional funding commitments from existing or new lenders. The Revolving Facility is available to finance working capital, capital expenditures and other lawful corporate purposes. The initial maturity date of the Revolving Facility is April 23, 2029, which may be extended by up to two years by exercising extension options provided in the Credit Agreement. At the Company’s option, loans under the Credit Agreement bear interest at (i) the Applicable Rate (as defined in the Credit Agreement) plus Term SOFR (as defined in the Credit Agreement) or (ii) the Applicable Rate plus a rate equal to the highest of (a) the federal funds rate plus 0.50%, (b) the prime rate of Bank of America, N.A., or (c) Term SOFR plus 1.00% (the “Base Rate”). All swing line loans bear interest at a rate equal to the Applicable Rate plus the Base Rate. Term SOFR is the rate per annum equal to the forward-looking SOFR term rate for interest periods of one, three or six months, as selected by the Company, plus an adjustment of 0.10%. The Applicable Rate is determined by reference to a pricing grid based on the Consolidated Leverage Ratio (as defined in the Credit Agreement) or, at the option of the Company, the Debt Rating (as defined in the Credit Agreement). The Applicable Rate for Term SOFR loans ranges from 1.000% per annum to 1.750% per annum and the Applicable Rate for Base Rate loans ranges from 0.000% per annum to 0.750% per annum. Undrawn amounts under the Revolving Facility are subject to a commitment fee ranging from 0.125% to 0.275%. Interest for Term SOFR loans is payable at the end of each applicable interest period or at three-month intervals, if such interest period exceeds three months. Interest for Base Rate loans is payable quarterly in arrears. The Company pays a letter of credit fee equal to the Applicable Rate multiplied by the daily amount available to be drawn under any letter of credit, a fronting fee and any customary documentary and processing charges for any letter of credit issued under the Credit Agreement. During the nine months ended December 28, 2024, there were no borrowings under the Revolving Facility. The Credit Agreement contains various conditions, covenants and representations with which the Company must be in compliance in order to borrow funds and avoid an event of default. As of December 28, 2024, the Company was in compliance with these covenants. Senior Notes due 2024 On December 14, 2021, the Company issued $500.0 million aggregate principal amount of its 1.750% senior notes due 2024 (the "2024 Notes"). In fiscal 2024, the Company repurchased $60.3 million of the principal amount of the 2024 Notes, plus accrued and unpaid interest, on the open market. In the first quarter of fiscal 2025, the Company repurchased $27.3 million of the principal amount of the 2024 Notes, plus accrued and unpaid interest, on the open market, and the Company recognized a net gain on debt extinguishment of $0.6 million, which is included in "Other income, net" in the Condensed Consolidated Statement of Operations. The Company repaid the remaining principal balance of $412.5 million of the 2024 Notes, plus accrued and unpaid interest, with cash on hand upon maturity in December 2024. The Company paid interest of $7.2 million and $8.6 million on the 2024 Notes during the nine months ended December 28, 2024 and December 30, 2023, respectively. Senior Notes due 2029 On September 30, 2019, the Company issued $350.0 million aggregate principal amount of its 4.375% senior notes due 2029 (the "Initial 2029 Notes"). On December 20, 2019, and June 11, 2020, the Company issued an additional $200.0 million and $300.0 million, respectively, aggregate principal amount of such notes (together, the "Additional 2029 Notes" and collectively with the Initial 2029 Notes, the "2029 Notes"). The 2029 Notes will mature on October 15, 2029, unless earlier redeemed in accordance with their terms. The 2029 Notes are senior unsecured obligations of the Company and are guaranteed, jointly and severally, by certain of the Company's U.S. subsidiaries (the "Guarantors"). The Initial 2029 Notes were issued pursuant to an indenture, dated as of September 30, 2019, by and among the Company, the Guarantors and MUFG Union Bank, N.A., as trustee, and the Additional 2029 Notes were issued pursuant to supplemental indentures, dated as of December 20, 2019, and June 11, 2020 (such indenture and supplemental indentures, collectively, the "2019 Indenture"). The 2019 Indenture contains customary events of default, including payment default, exchange default, failure to provide certain notices thereunder and certain provisions related to bankruptcy events. The 2019 Indenture also contains customary negative covenants. Interest is payable on the 2029 Notes on April 15 and October 15 of each year. The Company paid interest of $37.2 million on the 2029 Notes during both the nine months ended December 28, 2024 and December 30, 2023. Senior Notes due 2031 On September 29, 2020, the Company issued $700.0 million aggregate principal amount of its 3.375% senior notes due 2031 (the "2031 Notes"). The 2031 Notes will mature on April 1, 2031, unless earlier redeemed in accordance with their terms. The 2031 Notes are senior unsecured obligations of the Company and are guaranteed, jointly and severally, by the Guarantors. The 2031 Notes were issued pursuant to an indenture, dated as of September 29, 2020, by and among the Company, the Guarantors and MUFG Union Bank, N.A., as trustee (the "2020 Indenture"). The 2020 Indenture contains substantially the same customary events of default and negative covenants as the 2019 Indenture. Interest is payable on the 2031 Notes on April 1 and October 1 of each year. The Company paid interest of $23.6 million and $11.8 million on the 2031 Notes during the nine months ended December 28, 2024 and December 30, 2023, respectively. Fair Value of Debt The Company's debt is carried at amortized cost and is measured at fair value quarterly for disclosure purposes. The estimated fair value of the 2029 Notes and the 2031 Notes as of December 28, 2024 was $795.2 million and $598.7 million, respectively (compared to the outstanding principal amount of $850.0 million and $700.0 million, respectively). The estimated fair value of the 2024 Notes, the 2029 Notes and the 2031 Notes as of March 30, 2024 was $426.9 million, $797.6 million and $603.8 million, respectively (compared to the outstanding principal amount of $439.7 million, $850.0 million and $700.0 million, respectively). The Company considers its debt to be Level 2 in the fair value hierarchy. Fair values are estimated based on quoted market prices for identical or similar instruments. The 2029 Notes and the 2031 Notes currently trade over-the-counter, and the fair values were estimated based upon the value of the last trade at the end of the period. Interest Expense During the three and nine months ended December 28, 2024, the Company recognized $19.4 million and $61.4 million of interest expense , respectively, primarily related to the 2024 Notes, the 2029 Notes and the 2031 Notes, which was partially offset by interest capitalized to property and equipment of $0.8 million and $3.1 million, respectively. Interest expense for the three and nine months ended December 28, 2024 also includes financing costs related to certain inventory (subject to repurchase) in connection with a supply agreement. During the three and nine months ended December 30, 2023, the Company recognized $18.2 million and $54.2 million of interest expense, respectively, primarily related to the 2024 Notes, the 2029 Notes and the 2031 Notes, which was partially offset by interest capitalized to property and equipment of $0.6 million and $2.3 million, respectively.

Stock Repurchases

Stock Repurchases	9 Months Ended
	Dec. 28, 2024
Equity [Abstract]
STOCK REPURCHASES	9. STOCK REPURCHASES On November 2, 2022, the Company announced that its Board of Directors authorized a share repurchase program to repurchase up to $2.0 billion of the Company's outstanding common stock, which included the remaining authorized dollar amount under a prior program terminated concurrent with the new authorization. Under this program, share repurchases are made in accordance with applicable securities laws on the open market or in privately negotiated transactions. The extent to which the Company repurchases its shares, the number of shares and the timing of any repurchases depends on general market conditions, regulatory requirements, alternative investment opportunities and other considerations. The program does not require the Company to repurchase a minimum number of shares, does not have a fixed term, and may be modified, suspended or terminated at any time without prior notice. During the three and nine months ended December 28, 2024, the Company repurchased approximately 1.4 million and 3.3 million shares of its common stock, respectively, for approximately $100.8 million and $308.3 million, respectively (including transaction costs and excise tax). As of December 28, 2024, approximately $998.6 million remains authorized for repurchases under the current share repurchase program. During the three and nine months ended December 30, 2023, the Company repurchased approximately 1.1 million and 3.1 million shares of its common stock, respectively, for approximately $100.8 million and $302.0 million, respectively (including transaction costs and excise tax) under its share repurchase program.

Commitments and Contingent Liab

Commitments and Contingent Liabilities	9 Months Ended
	Dec. 28, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Text Block]	10. COMMITMENTS AND CONTINGENT LIABILITIES Legal Matters The Company is involved in various legal proceedings and claims that have arisen in the ordinary course of business that have not been fully adjudicated. The Company accrues a liability for legal contingencies when it believes that it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. The Company regularly evaluates developments in its legal matters that could affect the amount of the previously accrued liability and records adjustments as appropriate. Although it is not possible to predict with certainty the outcome of the unresolved legal matters, it is the opinion of management that these matters will not, individually or in the aggregate, have a material adverse effect on the Company’s consolidated financial position or results of operations. The aggregate range of reasonably possible losses in excess of accrued liabilities, if any, associated with these unresolved legal matters is not material.

Revenue

Revenue	9 Months Ended
	Dec. 28, 2024
Revenue from Contract with Customer [Abstract]
REVENUE	11. REVENUE Revenue by geographic region (based on the location of the customers' headquarters) is summarized as follows (in thousands): Three Months Ended Nine Months Ended December 28, 2024 December 30, 2023 December 28, 2024 December 30, 2023 United States $ 602,675 $ 652,477 $ 1,706,741 $ 1,667,048 China 139,548 201,172 487,745 541,878 Other Asia 79,760 144,584 324,981 355,313 Taiwan 69,386 60,775 264,238 192,793 Europe 24,948 14,853 65,792 71,486 Total revenue $ 916,317 $ 1,073,861 $ 2,849,497 $ 2,828,518 The Company also disaggregates revenue by operating segments (refer to Note 13).

Restructuring and Related Activ

Restructuring and Related Activities	9 Months Ended
	Dec. 28, 2024
Restructuring and Related Activities [Abstract]
RESTRUCTURING	12. RESTRUCTURING 2025 Restructuring Initiatives In fiscal 2025, the Company initiated actions to reduce operating expenses, streamline its manufacturing footprint and focus on opportunities that align with its long-term profitability objectives (the "2025 Restructuring Initiatives"). As part of these actions, the Company determined in the second quarter of fiscal 2025 that there was a more-likely-than-not expectation of divesting its SiC power device business and impairment testing was triggered, which resulted in inventory write-downs of $13.7 million (for inventory expected to be disposed of), impairment of intangible assets of $16.6 million and a goodwill impairment charge of approximately $96.5 million. Subsequently, in December 2024, the Company entered into a definitive agreement to divest its SiC power device business and on January 14, 2025, the sale was completed. In addition, the Company took actions in the third quarter of fiscal 2025 to optimize its manufacturing footprint and reduce operating expenses, which included workforce redu ctions primarily targeting the Company's mass-market Android business and the cancellation of certain multiyear projects to update the Company's core business syste ms. In accordance with ASC 420, "Exit or Disposal Cost Obligations," the Company recorded $6.4 million related to the termination of a contract before the end of its term and recorded $27.7 million for costs that will continue to be incurred under a contract for its remaining term without economic benefit to the Company. The Company also recorded asset impairments of $15.8 million related to the write-off of capitalized software costs in accordance with ASC 360. Refer to Note 6 for additional information regarding the impairment of goodwill and intangible assets. The following table summarizes the fiscal 2025 charges resulting from the 2025 Restructuring Initiatives (in thousands): Three Months Ended December 28, 2024 Cost of Goods Sold Goodwill Impairment Other Operating Expense Total Contract termination and other costs $ 6,231 $ — $ 38,005 $ 44,236 Asset impairment costs 699 — 15,819 16,518 One-time employee termination benefits — — 6,639 6,639 Total $ 6,930 $ — $ 60,463 $ 67,393 Nine Months Ended December 28, 2024 Cost of Goods Sold Goodwill Impairment Other Operating Expense Total Contract termination and other costs $ 6,231 $ — $ 41,053 $ 47,284 Asset impairment costs 14,359 96,458 32,585 143,402 One-time employee termination benefits — — 6,639 6,639 Total $ 20,590 $ 96,458 $ 80,277 $ 197,325 The following table summarizes the liability activity related to the 2025 Restructuring Initiatives for the nine months ended December 28, 2024 (in thousands): One-Time Employee Termination Benefits Contract Termination and Other Costs Total Accrued restructuring balance as of March 30, 2024 $ — $ — $ — Costs incurred and charged to expense 6,639 41,053 47,692 Cash payments (302) (9,413) (9,715) Accrued restructuring balance as of December 28, 2024 $ 6,337 $ 31,640 $ 37,977 2024 Restructuring Initiative In the third quarter of fiscal 2024 the Company entered into a definitive agreement with Luxshare to divest its assembly and test operations in Beijing and Dezhou, China. The sale of these operations (the "2024 Restructuring Initiative") was completed in the first quarter of fiscal 2025 (refer to Note 4 for additional information). The following table summarizes the fiscal 2025 charges resulting from the 2024 Restructuring Initiative (in thousands): Three Months Ended December 28, 2024 Nine Months Ended December 28, 2024 Cost of Goods Sold Other Operating Expense Total Cost of Goods Sold Other Operating Expense Total Contract termination and other costs $ — $ 181 $ 181 $ — $ 4,176 $ 4,176 Asset impairment costs (1) — — — 1,754 5,718 7,472 One-time employee termination benefits — 386 386 — 6,098 6,098 Total $ — $ 567 $ 567 $ 1,754 $ 15,992 $ 17,746 (1) Refer to Note 4 for additional information. The Company incurred immaterial legal and professional fees, recorded to "Other operating expense," in the third quarter of fiscal 2024 as a result of the 2024 Restructuring Initiative. As of December 28, 2024, the Company has recorded cumulative expenses of approximately $11.4 million, $44.4 million and $15.0 million for contract termination and other costs, asset impairment costs, and one-time employee termination benefits, respectively, as a result of the 2024 Restructuring Initiative. The Company does not expect to incur additional material charges related to the 2024 Restructuring Initiative. The following table summarizes the liability activity related to the 2024 Restructuring Initiative for the nine months ended December 28, 2024 (in thousands): One-Time Employee Termination Benefits Contract Termination and Other Costs Total Accrued restructuring balance as of March 30, 2024 $ 7,432 $ 4,080 $ 11,512 Costs incurred and charged to expense 6,098 4,176 10,274 Cash payments (12,512) (8,075) (20,587) Accrued restructuring balance as of December 28, 2024 $ 1,018 $ 181 $ 1,199 2023 Restructuring Initiatives During fiscal 2023, the Company initiated actions to improve efficiencies in its operations and further align the organization with its strategic objectives, which primarily included seeking strategic alternatives related to its biotechnology business (the "2023 Restructuring Initiatives"). The Company completed the sale of its biotechnology business in the third quarter of fiscal 2024. The Company incurred immaterial costs, recorded to "Other operating expense," in fiscal 2025 as a result of the 2023 Restructuring Initiatives. The following table summarizes the fiscal 2024 charges resulting from the 2023 Restructuring Initiatives (in thousands): Three Months Ended December 30, 2023 Nine Months Ended December 30, 2023 Cost of Goods Sold Other Operating Expense Total Cost of Goods Sold Other Operating Expense Total Contract termination and other costs (1) $ (250) $ 773 $ 523 $ 19,028 $ 3,530 $ 22,558 Asset impairment costs — 2,341 2,341 2,159 6,627 8,786 One-time employee termination benefits — 7 7 — 2,681 2,681 Total $ (250) $ 3,121 $ 2,871 $ 21,187 $ 12,838 $ 34,025 (1) Includes reversal due to adjustment of previously accrued restructuring charges. As of December 28, 2024, the Company has recorded cumulative expenses of approximately $46.3 million, $99.9 million, $12.4 million and $5.9 million for contract termination and other costs, asset impairment costs, goodwill impairment charges, and one-time employee termination benefits, respectively, as a result of the 2023 Restructuring Initiatives. The Company does not expect to incur additional material charges related to the 2023 Restructuring Initiatives. The following table summarizes the liability activity related to the 2023 Restructuring Initiatives for the nine months ended December 28, 2024 (in thousands): One-Time Employee Termination Benefits Contract Termination and Other Costs Total Accrued restructuring balance as of March 30, 2024 $ 347 $ 9,308 $ 9,655 Costs incurred and charged to expense 321 278 599 Cash payments (668) (9,494) (10,162) Accrued restructuring balance as of December 28, 2024 $ — $ 92 $ 92 In fiscal 2025, the Company incurred immaterial legal fees and other costs, recorded to "Other operating expense" in connection with other miscellaneous restructuring initiatives.

Operating Segment Information

Operating Segment Information	9 Months Ended
	Dec. 28, 2024
Segment Reporting [Abstract]
OPERATING SEGMENT INFORMATION	13. OPERATING SEGMENT INFORMATION The Company's three operating and reportable segments, HPA, CSG, and ACG, are based on the organizational structure and information reviewed by the Company's Chief Executive Officer, who is also the Company's chief operating decision maker ("CODM"). The CODM allocates resources and evaluates the performance of each of the three operating segments primarily based on operating income. The Company’s manufacturing facilities service and provide benefit to all three operating segments, and the operating costs of the facilities are reflected in the cost of goods sold for each operating segment. The Company’s operating segments do not record intercompany revenue. The Company does not allocate gains and losses from investments, interest expense, other income (expense), or taxes to operating segments. The CODM does not evaluate operating segments using discrete asset information. HPA is a leading global supplier of radio frequency ("RF"), analog mixed signal and power management solutions. HPA leverages a diverse portfolio of differentiated process technologies and products to serve customers in automotive, consumer, defense and aerospace, infrastructure, industrial and enterprise, and mobile markets. CSG is a leading global supplier of connectivity and sensor solutions. CSG leverages broad expertise spanning ultra-wideband, Matter ® , Bluetooth ® Low Energy, Zigbee ® , Thread ® , Wi-Fi ® , cellular Internet of Things, and microelectromechanical force sensing touch sensors to serve customers in automotive, consumer, industrial and enterprise, and mobile markets. ACG is a leading global supplier of advanced cellular RF solutions for smartphones and consumer devices including tablets and wearables. ACG leverages world-class technology and systems-level expertise to deliver a broad portfolio of high-performance discrete and highly integrated cellular products. The "All other" category includes operating expenses such as stock-based compensation expense, amortization of acquired intangible assets, restructuring-related charges, acquisition and integration-related costs, goodwill and other asset impairments, net adjustments related to a terminated capacity reservation agreement, gain or loss on assets, costs associated with upgrading certain of the Company's core business systems and other miscellaneous corporate overhead expenses that the Company does not allocate to its operating segments, because these expenses are not included in the segment operating performance measures evaluated by the Company’s CODM. Except as discussed above regarding the "All other" category, the Company’s accounting policies for segment reporting are the same as for the Company as a whole. The following tables present details of the Company’s operating and reportable segments and a reconciliation of the "All other" category (in thousands): Three Months Ended Nine Months Ended December 28, 2024 December 30, 2023 December 28, 2024 December 30, 2023 Revenue: HPA $ 171,678 $ 118,890 $ 449,397 $ 408,386 CSG 109,567 108,898 371,242 311,783 ACG 635,072 846,073 2,028,858 2,108,349 Total revenue $ 916,317 $ 1,073,861 $ 2,849,497 $ 2,828,518 Operating income (loss): HPA $ 32,580 $ 1,578 $ 50,527 $ 50,988 CSG (11,736) (25,590) (40,211) (73,476) ACG 161,228 263,792 492,734 593,595 All other (129,047) (281,349) (435,744) (509,384) Operating income (loss) 53,025 (41,569) 67,306 61,723 Interest expense (18,655) (17,581) (58,343) (51,963) Other income, net 14,526 15,359 41,713 34,286 Income (loss) before income taxes $ 48,896 $ (43,791) $ 50,676 $ 44,046 Three Months Ended Nine Months Ended December 28, 2024 December 30, 2023 December 28, 2024 December 30, 2023 Reconciliation of "All other" category: Stock-based compensation expense $ (28,384) $ (21,755) $ (108,931) $ (99,253) Amortization of intangible assets (26,085) (29,787) (86,041) (90,622) Restructuring-related charges (1) (68,072) (6,075) (122,042) (37,229) Acquisition and integration-related costs (1,382) (2,529) (5,175) (4,576) Goodwill impairment (2) — (173,414) (96,458) (221,414) Net adjustments related to a terminated capacity reservation agreement 1,253 (51,864) 4,724 (51,864) Other (6,377) 4,075 (21,821) (4,426) Loss from operations for "All other" $ (129,047) $ (281,349) $ (435,744) $ (509,384) (1) Refer to Note 12 for additional information. (2) Refer to Note 6 for additional information.

Income Taxes

Income Taxes	9 Months Ended
	Dec. 28, 2024
Income Tax Disclosure [Abstract]
INCOME TAXES	14. INCOME TAXES The Company’s income tax expense was $7.6 million and $26.4 million for the three and nine months ended December 28, 2024, respectively, and $83.1 million and $117.1 million for the three and nine months ended December 30, 2023, respectively. The Company’s effective tax rate was 15.6% and 52.1% for the three and nine months ended December 28, 2024, respectively, and (189.9)% and 265.9% for the three and nine months ended December 30, 2023, respectively. The Company's effective tax rate for the three and nine months ended December 28, 2024 differed from the statutory rate primarily due to tax rate differences in foreign jurisdictions, Global Intangible Low-Taxed Income ("GILTI"), domestic tax credits generated, discrete pretax items and discrete tax items. After consideration of pretax items taxed discretely in the period, the Company recognized tax expense associated with its ongoing operations and the period-to-date income, which was partially offset by discrete tax benefits of $11.4 million and $11.2 million for the three and nine months ended December 28, 2024, respectively. The discrete tax benefit for the three and nine months ended December 28, 2024 primarily related to the tax impacts of the 2025 Restructuring Initiatives (refer to Note 12 for additional information). For the nine months ended December 28, 2024, this tax benefit was partially offset by the tax effects of the sale of the Company's assembly and test operations in China (refer to Note 4 for additional information).

Net Income Per Share

Net Income Per Share	9 Months Ended
	Dec. 28, 2024
Earnings Per Share [Abstract]
NET INCOME PER SHARE	15. NET INCOME (LOSS) PER SHARE The following table sets forth the computation of basic and diluted net income (loss) per share (in thousands, except per share data): Three Months Ended Nine Months Ended December 28, 2024 December 30, 2023 December 28, 2024 December 30, 2023 Numerator: Numerator for basic and diluted net income (loss) per share — net income (loss) available to common stockholders $ 41,271 $ (126,938) $ 24,250 $ (73,057) Denominator: Denominator for basic net income (loss) per share — weighted-average shares 94,341 97,152 94,942 97,905 Effect of dilutive securities: Stock-based awards 690 — 866 — Denominator for diluted net income (loss) per share — adjusted weighted-average shares and assumed conversions 95,031 97,152 95,808 97,905 Basic net income (loss) per share $ 0.44 $ (1.31) $ 0.26 $ (0.75) Diluted net income (loss) per share $ 0.43 $ (1.31) $ 0.25 $ (0.75) In the computation of diluted net income per share for the three and nine months ended December 28, 2024, approximately 2.0 million and 0.8 million shares, respectively, of outstanding stock-based awards were excluded because the effect of their inclusion would have been anti-dilutive. In the computation of net loss per share for the three and nine months ended December 30, 2023, approximately 2.2 million and 1.6 million shares, respectively, of outstanding stock-based awards were excluded because the effect of their inclusion would have been anti-dilutive.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 28, 2024	Dec. 30, 2023	Dec. 28, 2024	Dec. 30, 2023
Pay vs Performance Disclosure
Numerator for basic and diluted net income (loss) per share — net income (loss) available to common stockholders	$ 41,271	$ (126,938)	$ 24,250	$ (73,057)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Dec. 28, 2024
Trading Arrangements, by Individual
Material Terms of Trading Arrangement	OTHER INFORMATION. Rule 10b5-1 and Non-Rule 10b5-1 Trading Arrangements During the third quarter of fiscal 2025, no director or Section 16 officer adopted or terminated a "Rule 10b5-1 trading agreement" or a "non-Rule 10b5-1 trading arrangement," as each term is defined in Item 408 of Regulation S-K.
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false

Long-Term Debt Fair Value of De

Long-Term Debt Fair Value of Debt (Policies)	9 Months Ended
	Dec. 28, 2024
Debt Disclosure [Abstract]
Fair value of debt [Policy Text Block]	The Company's debt is carried at amortized cost and is measured at fair value quarterly for disclosure purposes. The estimated fair value of the 2029 Notes and the 2031 Notes as of December 28, 2024 was $795.2 million and $598.7 million, respectively (compared to the outstanding principal amount of $850.0 million and $700.0 million, respectively). The estimated fair value of the 2024 Notes, the 2029 Notes and the 2031 Notes as of March 30, 2024 was $426.9 million, $797.6 million and $603.8 million, respectively (compared to the outstanding principal amount of $439.7 million, $850.0 million and $700.0 million, respectively). The Company considers its debt to be Level 2 in the fair value hierarchy. Fair values are estimated based on quoted market prices for identical or similar instruments. The 2029 Notes and the 2031 Notes currently trade over-the-counter, and the fair values were estimated based upon the value of the last trade at the end of the period.

Operating Segment Information S

Operating Segment Information Segment Policy (Policies)	9 Months Ended
	Dec. 28, 2024
Segment Reporting [Abstract]
Segment Reporting, Policy [Policy Text Block]	The Company's three operating and reportable segments, HPA, CSG, and ACG, are based on the organizational structure and information reviewed by the Company's Chief Executive Officer, who is also the Company's chief operating decision maker ("CODM"). The CODM allocates resources and evaluates the performance of each of the three operating segments primarily based on operating income. The Company’s manufacturing facilities service and provide benefit to all three operating segments, and the operating costs of the facilities are reflected in the cost of goods sold for each operating segment. The Company’s operating segments do not record intercompany revenue. The Company does not allocate gains and losses from investments, interest expense, other income (expense), or taxes to operating segments. The CODM does not evaluate operating segments using discrete asset information. HPA is a leading global supplier of radio frequency ("RF"), analog mixed signal and power management solutions. HPA leverages a diverse portfolio of differentiated process technologies and products to serve customers in automotive, consumer, defense and aerospace, infrastructure, industrial and enterprise, and mobile markets. CSG is a leading global supplier of connectivity and sensor solutions. CSG leverages broad expertise spanning ultra-wideband, Matter ® , Bluetooth ® Low Energy, Zigbee ® , Thread ® , Wi-Fi ® , cellular Internet of Things, and microelectromechanical force sensing touch sensors to serve customers in automotive, consumer, industrial and enterprise, and mobile markets. ACG is a leading global supplier of advanced cellular RF solutions for smartphones and consumer devices including tablets and wearables. ACG leverages world-class technology and systems-level expertise to deliver a broad portfolio of high-performance discrete and highly integrated cellular products. The "All other" category includes operating expenses such as stock-based compensation expense, amortization of acquired intangible assets, restructuring-related charges, acquisition and integration-related costs, goodwill and other asset impairments, net adjustments related to a terminated capacity reservation agreement, gain or loss on assets, costs associated with upgrading certain of the Company's core business systems and other miscellaneous corporate overhead expenses that the Company does not allocate to its operating segments, because these expenses are not included in the segment operating performance measures evaluated by the Company’s CODM. Except as discussed above regarding the "All other" category, the Company’s accounting policies for segment reporting are the same as for the Company as a whole.

Inventories (Tables)

Inventories (Tables)	9 Months Ended
	Dec. 28, 2024
Inventory Disclosure [Abstract]
Components of inventories	The components of inventories, net of reserves, are as follows (in thousands): December 28, 2024 (1) March 30, 2024 Raw materials $ 202,661 $ 201,748 Work in process 311,046 347,175 Finished goods 142,509 161,632 Total inventories $ 656,216 $ 710,555 (1) Excludes $35.3 million of inventories, net of reserves, which has been reclassified to "Assets of disposal group held for sale." Refer to Note 5 for additional information.

Business Held for Sale - Disp_2

Business Held for Sale - Disposal Groups (Tables)	9 Months Ended
	Dec. 28, 2024
Discontinued Operations and Disposal Groups [Abstract]
Disposal Groups, Including Discontinued Operations	The carrying values of the major classes of assets and liabilities classified as held for sale as of December 28, 2024 are as follows (in thousands): Intangible assets, net $ 74,034 Inventories 35,317 Other assets 7,084 Total assets of disposal group held for sale $ 116,435 Accounts payable and accrued liabilities $ 14,008 Deferred tax liabilities 13,407 Other liabilities 1,660 Total liabilities of disposal group held for sale $ 29,075

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	9 Months Ended
	Dec. 28, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill [Table Text Block]	The changes in the carrying amount of goodwill are as follows (in thousands): HPA CSG ACG Total Balance as of March 30, 2024 (1) $ 517,542 $ 300,299 $ 1,716,760 $ 2,534,601 Goodwill impairment (96,458) — — (96,458) Goodwill written off related to sale of business (2) — (200) (800) (1,000) Anokiwave, Inc. measurement period adjustments 91 — — 91 Balance as of December 28, 2024 (1) $ 421,175 $ 300,099 $ 1,715,960 $ 2,437,234 (1) The Company’s goodwill balance is presented net of accumulated impairment losses totaling $999.9 million and $903.4 million as of December 28, 2024 and March 30, 2024, respectively, which were recognized in fiscal years 2009, 2013, 2014, 2022, 2023, 2024 and 2025. (2) Refer to Note 4 for additional information.
Schedule of finite-lived and indefinite-lived intangible assets [Table Text Block]	The following table summarizes information regarding the gross carrying amounts and accumulated amortization of intangible assets (in thousands): December 28, 2024 March 30, 2024 Gross Accumulated Gross Accumulated Developed technology (1) $ 690,472 $ 440,322 $ 903,089 $ 484,347 Customer relationships (1) 80,800 59,813 100,040 67,999 Technology licenses 74,519 23,388 54,869 6,525 Trade names 700 204 1,610 939 In-process research and development 9,574 N/A 9,585 N/A Total (2) $ 856,065 $ 523,727 $ 1,069,193 $ 559,810 (1) The December 28, 2024 balances exclude $109.5 million of gross carrying amount and $35.5 million of accumulated amortization for Developed technology, as well as $19.2 million of both gross carrying amount and accumulated amortization for Customer relationships of the SiC Disposal Group which has been reclassified to "Assets of disposal group held for sale." Refer to Note 5 for additional information. (2) Amounts include the impact of foreign currency translation.

Debt (Tables)

Debt (Tables)	9 Months Ended
	Dec. 28, 2024
Debt Disclosure [Abstract]
Schedule of Long-term Debt Instruments	The following table summarizes the Company's outstanding debt (in thousands): December 28, 2024 March 30, 2024 1.750% senior notes due 2024 $ — $ 439,738 4.375% senior notes due 2029 850,000 850,000 3.375% senior notes due 2031 700,000 700,000 Unamortized premium, discount and issuance costs, net (770) (1,726) Total debt 1,549,230 1,988,012 Less current portion of debt — (438,740) Total long-term debt $ 1,549,230 $ 1,549,272

Revenue (Tables)

Revenue (Tables)	9 Months Ended
	Dec. 28, 2024
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue	Revenue by geographic region (based on the location of the customers' headquarters) is summarized as follows (in thousands): Three Months Ended Nine Months Ended December 28, 2024 December 30, 2023 December 28, 2024 December 30, 2023 United States $ 602,675 $ 652,477 $ 1,706,741 $ 1,667,048 China 139,548 201,172 487,745 541,878 Other Asia 79,760 144,584 324,981 355,313 Taiwan 69,386 60,775 264,238 192,793 Europe 24,948 14,853 65,792 71,486 Total revenue $ 916,317 $ 1,073,861 $ 2,849,497 $ 2,828,518

Restructuring and Related Act_2

Restructuring and Related Activities (Tables)	9 Months Ended
	Dec. 28, 2024
Restructuring and Related Activities [Abstract]
Schedule of restructuring activity	The following table summarizes the fiscal 2025 charges resulting from the 2025 Restructuring Initiatives (in thousands): Three Months Ended December 28, 2024 Cost of Goods Sold Goodwill Impairment Other Operating Expense Total Contract termination and other costs $ 6,231 $ — $ 38,005 $ 44,236 Asset impairment costs 699 — 15,819 16,518 One-time employee termination benefits — — 6,639 6,639 Total $ 6,930 $ — $ 60,463 $ 67,393 Nine Months Ended December 28, 2024 Cost of Goods Sold Goodwill Impairment Other Operating Expense Total Contract termination and other costs $ 6,231 $ — $ 41,053 $ 47,284 Asset impairment costs 14,359 96,458 32,585 143,402 One-time employee termination benefits — — 6,639 6,639 Total $ 20,590 $ 96,458 $ 80,277 $ 197,325 The following table summarizes the fiscal 2025 charges resulting from the 2024 Restructuring Initiative (in thousands): Three Months Ended December 28, 2024 Nine Months Ended December 28, 2024 Cost of Goods Sold Other Operating Expense Total Cost of Goods Sold Other Operating Expense Total Contract termination and other costs $ — $ 181 $ 181 $ — $ 4,176 $ 4,176 Asset impairment costs (1) — — — 1,754 5,718 7,472 One-time employee termination benefits — 386 386 — 6,098 6,098 Total $ — $ 567 $ 567 $ 1,754 $ 15,992 $ 17,746 (1) Refer to Note 4 for additional information. The Company incurred immaterial legal and professional fees, recorded to "Other operating expense," in the third quarter of fiscal 2024 as a result of the 2024 Restructuring Initiative. The following table summarizes the fiscal 2024 charges resulting from the 2023 Restructuring Initiatives (in thousands): Three Months Ended December 30, 2023 Nine Months Ended December 30, 2023 Cost of Goods Sold Other Operating Expense Total Cost of Goods Sold Other Operating Expense Total Contract termination and other costs (1) $ (250) $ 773 $ 523 $ 19,028 $ 3,530 $ 22,558 Asset impairment costs — 2,341 2,341 2,159 6,627 8,786 One-time employee termination benefits — 7 7 — 2,681 2,681 Total $ (250) $ 3,121 $ 2,871 $ 21,187 $ 12,838 $ 34,025
Restructuring Liabilities Rollforward	The following table summarizes the liability activity related to the 2025 Restructuring Initiatives for the nine months ended December 28, 2024 (in thousands): One-Time Employee Termination Benefits Contract Termination and Other Costs Total Accrued restructuring balance as of March 30, 2024 $ — $ — $ — Costs incurred and charged to expense 6,639 41,053 47,692 Cash payments (302) (9,413) (9,715) Accrued restructuring balance as of December 28, 2024 $ 6,337 $ 31,640 $ 37,977 The following table summarizes the liability activity related to the 2024 Restructuring Initiative for the nine months ended December 28, 2024 (in thousands): One-Time Employee Termination Benefits Contract Termination and Other Costs Total Accrued restructuring balance as of March 30, 2024 $ 7,432 $ 4,080 $ 11,512 Costs incurred and charged to expense 6,098 4,176 10,274 Cash payments (12,512) (8,075) (20,587) Accrued restructuring balance as of December 28, 2024 $ 1,018 $ 181 $ 1,199 The following table summarizes the liability activity related to the 2023 Restructuring Initiatives for the nine months ended December 28, 2024 (in thousands): One-Time Employee Termination Benefits Contract Termination and Other Costs Total Accrued restructuring balance as of March 30, 2024 $ 347 $ 9,308 $ 9,655 Costs incurred and charged to expense 321 278 599 Cash payments (668) (9,494) (10,162) Accrued restructuring balance as of December 28, 2024 $ — $ 92 $ 92

Operating Segment Information (

Operating Segment Information (Tables)	9 Months Ended
	Dec. 28, 2024
Segment Reporting [Abstract]
Summary of details of reportable segments	The following tables present details of the Company’s operating and reportable segments and a reconciliation of the "All other" category (in thousands): Three Months Ended Nine Months Ended December 28, 2024 December 30, 2023 December 28, 2024 December 30, 2023 Revenue: HPA $ 171,678 $ 118,890 $ 449,397 $ 408,386 CSG 109,567 108,898 371,242 311,783 ACG 635,072 846,073 2,028,858 2,108,349 Total revenue $ 916,317 $ 1,073,861 $ 2,849,497 $ 2,828,518 Operating income (loss): HPA $ 32,580 $ 1,578 $ 50,527 $ 50,988 CSG (11,736) (25,590) (40,211) (73,476) ACG 161,228 263,792 492,734 593,595 All other (129,047) (281,349) (435,744) (509,384) Operating income (loss) 53,025 (41,569) 67,306 61,723 Interest expense (18,655) (17,581) (58,343) (51,963) Other income, net 14,526 15,359 41,713 34,286 Income (loss) before income taxes $ 48,896 $ (43,791) $ 50,676 $ 44,046
Summary of reconciliation of "All other" category	Three Months Ended Nine Months Ended December 28, 2024 December 30, 2023 December 28, 2024 December 30, 2023 Reconciliation of "All other" category: Stock-based compensation expense $ (28,384) $ (21,755) $ (108,931) $ (99,253) Amortization of intangible assets (26,085) (29,787) (86,041) (90,622) Restructuring-related charges (1) (68,072) (6,075) (122,042) (37,229) Acquisition and integration-related costs (1,382) (2,529) (5,175) (4,576) Goodwill impairment (2) — (173,414) (96,458) (221,414) Net adjustments related to a terminated capacity reservation agreement 1,253 (51,864) 4,724 (51,864) Other (6,377) 4,075 (21,821) (4,426) Loss from operations for "All other" $ (129,047) $ (281,349) $ (435,744) $ (509,384) (1) Refer to Note 12 for additional information. (2) Refer to Note 6 for additional information.

Net Income Per Share (Tables)

Net Income Per Share (Tables)	9 Months Ended
	Dec. 28, 2024
Earnings Per Share [Abstract]
Reconciliation of the numerators and denominators in the computation of basic and diluted net loss per share	The following table sets forth the computation of basic and diluted net income (loss) per share (in thousands, except per share data): Three Months Ended Nine Months Ended December 28, 2024 December 30, 2023 December 28, 2024 December 30, 2023 Numerator: Numerator for basic and diluted net income (loss) per share — net income (loss) available to common stockholders $ 41,271 $ (126,938) $ 24,250 $ (73,057) Denominator: Denominator for basic net income (loss) per share — weighted-average shares 94,341 97,152 94,942 97,905 Effect of dilutive securities: Stock-based awards 690 — 866 — Denominator for diluted net income (loss) per share — adjusted weighted-average shares and assumed conversions 95,031 97,152 95,808 97,905 Basic net income (loss) per share $ 0.44 $ (1.31) $ 0.26 $ (0.75) Diluted net income (loss) per share $ 0.43 $ (1.31) $ 0.25 $ (0.75)

Inventories (Details)

Inventories (Details) - USD ($) $ in Thousands	Dec. 28, 2024	Mar. 30, 2024
Components of inventories
Raw materials	$ 202,661	$ 201,748
Work in process	311,046	347,175
Finished goods	142,509	161,632
Total inventories	$ 656,216	$ 710,555

Business Divestiture (Details)

Business Divestiture (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 28, 2024	Jun. 29, 2024	Mar. 30, 2024	Dec. 28, 2024	Dec. 09, 2024	May 02, 2024	Dec. 16, 2023
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Disposal Group, Including Discontinued Operation, Inventory				$ 35,317		$ 127,000
Disposal Group, Including Discontinued Operation, Other Assets				7,084
Disposal Group, Including Discontinued Operation, Goodwill			$ 22,000
Disposal Group, Including Discontinued Operation, Other Liabilities				1,660
Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal	$ 2,000	$ 8,000	35,300
Disposal Group, Including Discontinued Operation, Assets			159,278	$ 116,435
Disposal Group, Including Discontinued Operation, Consideration	234,000				$ 115,000	232,000	$ 240,000
Disposal group, including discontinued operation, Net Assets	$ 76,000
Disposal Group, Including Discontinued Operation, Cash			$ 20,000			$ 29,000
Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down		$ 1,000

Business Held for Sale - Disp_3

Business Held for Sale - Disposal Groups (Details) - USD ($) $ in Thousands	3 Months Ended			9 Months Ended
	Dec. 28, 2024	Sep. 28, 2024	Dec. 30, 2023	Dec. 28, 2024	Dec. 30, 2023	Dec. 09, 2024	May 02, 2024	Mar. 30, 2024	Dec. 16, 2023
Discontinued Operations and Disposal Groups [Abstract]
Inventory Write-down		$ 13,700
Goodwill, Impairment Loss	$ 0	96,500	$ 173,414	$ 96,458	$ 221,414
Disposal Group, Including Discontinued Operation, Consideration		$ 234,000				$ 115,000	$ 232,000		$ 240,000
Disposal Group, Including Discontinued Operation, Intangible Assets	74,034			74,034
Disposal Group, Including Discontinued Operation, Inventory	35,317			35,317			$ 127,000
Disposal Group, Including Discontinued Operation, Other Assets	7,084			7,084
Disposal Group, Including Discontinued Operation, Assets	116,435			116,435				$ 159,278
Disposal Group, Including Discontinued Operation, Accounts Payable and Accrued Liabilities	14,008			14,008
Disposal Group, Including Discontinued Operation, Deferred Tax Liabilities	13,407			13,407
Disposal Group, Including Discontinued Operation, Other Liabilities	1,660			1,660
Disposal Group, Including Discontinued Operation, Liabilities	$ 29,075			$ 29,075				$ 88,372

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets (Details) - USD ($) $ in Thousands	3 Months Ended			9 Months Ended
	Dec. 28, 2024	Sep. 28, 2024	Dec. 30, 2023	Dec. 28, 2024	Dec. 30, 2023	Mar. 30, 2024
Goodwill and Intangible Assets [Line Items]
Intangible assets amortization				$ 103,146	$ 92,308
Goodwill	$ 2,437,234			2,437,234		$ 2,534,601
Goodwill, Impairment Loss	0	$ (96,500)	$ (173,414)	(96,458)	$ (221,414)
Goodwill, Written off Related to Sale of Business Unit				1,000
Goodwill, Accumulated impairment losses and write-offs	999,900			999,900		903,400
Accumulated Amortization	523,727			523,727		559,810
Gross Carrying Amount	856,065			856,065		1,069,193
Technology licenses
Goodwill and Intangible Assets [Line Items]
Gross Carrying Amount	74,519			74,519		54,869
Accumulated Amortization	23,388			23,388		6,525
Trade Names
Goodwill and Intangible Assets [Line Items]
Gross Carrying Amount	700			700		1,610
Accumulated Amortization	204			204		939
Developed Technology
Goodwill and Intangible Assets [Line Items]
Gross Carrying Amount	690,472			690,472		903,089
Accumulated Amortization	440,322			440,322		484,347
Customer Relationships
Goodwill and Intangible Assets [Line Items]
Gross Carrying Amount	80,800			80,800		100,040
Accumulated Amortization	59,813			59,813		67,999
In-process research and development
Goodwill and Intangible Assets [Line Items]
IPRD	9,574			9,574		9,585
HPA
Goodwill and Intangible Assets [Line Items]
Goodwill	421,175			421,175		517,542
Goodwill, Impairment Loss				(96,458)
Goodwill, Written off Related to Sale of Business Unit				0
CSG
Goodwill and Intangible Assets [Line Items]
Goodwill	300,099			300,099		300,299
Goodwill, Impairment Loss				0
Goodwill, Written off Related to Sale of Business Unit				200
ACG
Goodwill and Intangible Assets [Line Items]
Goodwill	1,715,960			1,715,960		$ 1,716,760
Goodwill, Impairment Loss				0
Goodwill, Written off Related to Sale of Business Unit				800
Anokiwave
Goodwill and Intangible Assets [Line Items]
Goodwill, Purchase Accounting Adjustments				91
Anokiwave | HPA
Goodwill and Intangible Assets [Line Items]
Goodwill, Purchase Accounting Adjustments				91
Anokiwave | CSG
Goodwill and Intangible Assets [Line Items]
Goodwill, Purchase Accounting Adjustments				0
Anokiwave | ACG
Goodwill and Intangible Assets [Line Items]
Goodwill, Purchase Accounting Adjustments				0
United Silicon Carbide, Inc. | Developed Technology
Goodwill and Intangible Assets [Line Items]
Gross Carrying Amount	109,500			109,500
Accumulated Amortization	35,500			35,500
United Silicon Carbide, Inc. | Customer Relationships
Goodwill and Intangible Assets [Line Items]
Gross Carrying Amount	$ 19,200			$ 19,200

Investments and Fair Value of_2

Investments and Fair Value of Financial Instruments (Details) - USD ($) $ in Millions	Dec. 28, 2024	Mar. 30, 2024
Mutual Fund
Fair Value, Measured on Recurring Basis, Gain (Loss) Included in Earnings [Line Items]
Deferred Compensation Plan Assets	$ 61.7	$ 52.3

Debt (Details)

Debt (Details) - USD ($)		3 Months Ended		9 Months Ended
	Apr. 23, 2024	Dec. 28, 2024	Dec. 30, 2023	Dec. 28, 2024	Dec. 30, 2023	Dec. 16, 2024	Mar. 30, 2024	Dec. 14, 2021	Sep. 29, 2020	Jun. 11, 2020	Dec. 20, 2019	Sep. 30, 2019
Debt Instrument [Line Items]
Long-term debt		$ 1,549,230,000		$ 1,549,230,000			$ 1,549,272,000
Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net		(770,000)		(770,000)			(1,726,000)
Debt, Long-Term and Short-Term, Combined Amount		1,549,230,000		1,549,230,000			1,988,012,000
Long-term Debt, Current Maturities		0		0			(438,740,000)
Interest Expense, Borrowings		19,400,000	$ 18,200,000	61,400,000	$ 54,200,000
Interest Costs Capitalized		800,000	600,000	3,100,000	2,300,000
Interest expense		18,655,000	$ 17,581,000	58,343,000	51,963,000
4.375% senior notes due 2029
Debt Instrument [Line Items]
Debt Instrument, Face Amount		850,000,000		850,000,000			850,000,000			$ 300,000,000	$ 200,000,000	$ 350,000,000
Interest Paid, Including Capitalized Interest, Operating and Investing Activities				37,200,000	37,200,000
Debt Instrument, Interest Rate, Stated Percentage												4.375%
4.375% senior notes due 2029 | Fair Value, Inputs, Level 2 [Member]
Debt Instrument [Line Items]
Long-term Debt, Fair Value		795,200,000		795,200,000			797,600,000
3.375% Senior Notes due 2031 [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount		700,000,000		700,000,000			700,000,000		$ 700,000,000
Interest Paid, Including Capitalized Interest, Operating and Investing Activities				23,600,000	11,800,000
Debt Instrument, Interest Rate, Stated Percentage									3.375%
3.375% Senior Notes due 2031 [Member] | Fair Value, Inputs, Level 2 [Member]
Debt Instrument [Line Items]
Long-term Debt, Fair Value		598,700,000		598,700,000			603,800,000
Senior Notes Due 2024 1.750%
Debt Instrument [Line Items]
Debt Instrument, Face Amount		0		0		$ 412,500,000	439,738,000	$ 500,000,000
Interest Paid, Including Capitalized Interest, Operating and Investing Activities				7,200,000	$ 8,600,000
Debt Instrument, Interest Rate, Stated Percentage								1.75%
Debt Instrument, Repurchased Face Amount		27,300,000		27,300,000			60,300,000
Gain (Loss) on Repurchase of Debt Instrument		600,000
Senior Notes Due 2024 1.750% | Fair Value, Inputs, Level 2 [Member]
Debt Instrument [Line Items]
Long-term Debt, Fair Value							$ 426,900,000
Credit Agreement | Federal Funds Rate
Debt Instrument [Line Items]
Debt Instrument, Basis Spread on Variable Rate	0.50%
Credit Agreement | Base Rate [Member]
Debt Instrument [Line Items]
Debt Instrument, Basis Spread on Variable Rate	1%
Credit Agreement | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate
Debt Instrument [Line Items]
Debt Instrument, Basis Spread on Variable Rate	0.10%
Credit Agreement | Maximum [Member] | Base Rate [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	0.75%
Credit Agreement | Maximum [Member] | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	1.75%
Credit Agreement | Maximum [Member] | Loan Purchase Commitments
Debt Instrument [Line Items]
Line of Credit Facility, Unused Capacity, Commitment Fee Percentage	0.275%
Credit Agreement | Minimum [Member] | Base Rate [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	0%
Credit Agreement | Minimum [Member] | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	1%
Credit Agreement | Minimum [Member] | Loan Purchase Commitments
Debt Instrument [Line Items]
Line of Credit Facility, Unused Capacity, Commitment Fee Percentage	0.125%
Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Proceeds from Lines of Credit		$ 0		$ 0
Revolving Credit Facility [Member] | Credit Agreement
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	$ 325,000,000
Revolving Credit Facility [Member] | Credit Agreement | Standby Letters of Credit [Member]
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	25,000,000
Revolving Credit Facility [Member] | Credit Agreement | Swing line advances
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	$ 10,000,000

Stock Repurchases (Details)

Stock Repurchases (Details) - USD ($) $ in Thousands, shares in Millions	3 Months Ended		9 Months Ended
	Dec. 28, 2024	Dec. 30, 2023	Dec. 28, 2024	Dec. 30, 2023	Nov. 02, 2022
Class of Stock [Line Items]
Stock Repurchased During Period, Shares	1.4	1.1	3.3	3.1
Stock Repurchased During Period, Value	$ 100,825	$ 100,812	$ 308,296	$ 301,978
Stock Repurchase Program, Remaining Authorized Repurchase Amount	$ 998,600		$ 998,600
Document Period End Date			Dec. 28, 2024
November 2, 2022 Program
Class of Stock [Line Items]
Stock Repurchase Program, Authorized Amount					$ 2,000,000

Revenue (Details)

Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 28, 2024	Dec. 30, 2023	Dec. 28, 2024	Dec. 30, 2023
Disaggregation of Revenue
Revenues	$ 916,317	$ 1,073,861	$ 2,849,497	$ 2,828,518
China
Disaggregation of Revenue
Revenues	139,548	201,172	487,745	541,878
Taiwan
Disaggregation of Revenue
Revenues	69,386	60,775	264,238	192,793
United States
Disaggregation of Revenue
Revenues	602,675	652,477	1,706,741	1,667,048
Europe
Disaggregation of Revenue
Revenues	24,948	14,853	65,792	71,486
Other Asia
Disaggregation of Revenue
Revenues	$ 79,760	$ 144,584	$ 324,981	$ 355,313

Restructuring and Related Act_3

Restructuring and Related Activities (Details) - USD ($) $ in Thousands	3 Months Ended			9 Months Ended		15 Months Ended	27 Months Ended
	Dec. 28, 2024	Sep. 28, 2024	Dec. 30, 2023	Dec. 28, 2024	Dec. 30, 2023	Dec. 28, 2024	Dec. 28, 2024	Mar. 30, 2024
Restructuring and Related Activities [Abstract]
Restructuring and Related Cost, Incurred Cost	$ 27,700
Restructuring
Restructuring and Related Cost, Incurred Cost	27,700
Goodwill, Impairment Loss	0	$ 96,500	$ 173,414	$ 96,458	$ 221,414
Schedule of restructuring activity				The following table summarizes the fiscal 2025 charges resulting from the 2025 Restructuring Initiatives (in thousands): Three Months Ended December 28, 2024 Cost of Goods Sold Goodwill Impairment Other Operating Expense Total Contract termination and other costs $ 6,231 $ — $ 38,005 $ 44,236 Asset impairment costs 699 — 15,819 16,518 One-time employee termination benefits — — 6,639 6,639 Total $ 6,930 $ — $ 60,463 $ 67,393 Nine Months Ended December 28, 2024 Cost of Goods Sold Goodwill Impairment Other Operating Expense Total Contract termination and other costs $ 6,231 $ — $ 41,053 $ 47,284 Asset impairment costs 14,359 96,458 32,585 143,402 One-time employee termination benefits — — 6,639 6,639 Total $ 20,590 $ 96,458 $ 80,277 $ 197,325 The following table summarizes the fiscal 2025 charges resulting from the 2024 Restructuring Initiative (in thousands): Three Months Ended December 28, 2024 Nine Months Ended December 28, 2024 Cost of Goods Sold Other Operating Expense Total Cost of Goods Sold Other Operating Expense Total Contract termination and other costs $ — $ 181 $ 181 $ — $ 4,176 $ 4,176 Asset impairment costs (1) — — — 1,754 5,718 7,472 One-time employee termination benefits — 386 386 — 6,098 6,098 Total $ — $ 567 $ 567 $ 1,754 $ 15,992 $ 17,746 (1) Refer to Note 4 for additional information. The Company incurred immaterial legal and professional fees, recorded to "Other operating expense," in the third quarter of fiscal 2024 as a result of the 2024 Restructuring Initiative. The following table summarizes the fiscal 2024 charges resulting from the 2023 Restructuring Initiatives (in thousands): Three Months Ended December 30, 2023 Nine Months Ended December 30, 2023 Cost of Goods Sold Other Operating Expense Total Cost of Goods Sold Other Operating Expense Total Contract termination and other costs (1) $ (250) $ 773 $ 523 $ 19,028 $ 3,530 $ 22,558 Asset impairment costs — 2,341 2,341 2,159 6,627 8,786 One-time employee termination benefits — 7 7 — 2,681 2,681 Total $ (250) $ 3,121 $ 2,871 $ 21,187 $ 12,838 $ 34,025
Restructuring Liabilities Rollforward				The following table summarizes the liability activity related to the 2025 Restructuring Initiatives for the nine months ended December 28, 2024 (in thousands): One-Time Employee Termination Benefits Contract Termination and Other Costs Total Accrued restructuring balance as of March 30, 2024 $ — $ — $ — Costs incurred and charged to expense 6,639 41,053 47,692 Cash payments (302) (9,413) (9,715) Accrued restructuring balance as of December 28, 2024 $ 6,337 $ 31,640 $ 37,977 The following table summarizes the liability activity related to the 2024 Restructuring Initiative for the nine months ended December 28, 2024 (in thousands): One-Time Employee Termination Benefits Contract Termination and Other Costs Total Accrued restructuring balance as of March 30, 2024 $ 7,432 $ 4,080 $ 11,512 Costs incurred and charged to expense 6,098 4,176 10,274 Cash payments (12,512) (8,075) (20,587) Accrued restructuring balance as of December 28, 2024 $ 1,018 $ 181 $ 1,199 The following table summarizes the liability activity related to the 2023 Restructuring Initiatives for the nine months ended December 28, 2024 (in thousands): One-Time Employee Termination Benefits Contract Termination and Other Costs Total Accrued restructuring balance as of March 30, 2024 $ 347 $ 9,308 $ 9,655 Costs incurred and charged to expense 321 278 599 Cash payments (668) (9,494) (10,162) Accrued restructuring balance as of December 28, 2024 $ — $ 92 $ 92
impairment charges
Restructuring and Related Activities [Abstract]
Restructuring Charges	15,800
Restructuring
Restructuring Charges	15,800
Lease and other contract terminations
Restructuring and Related Activities [Abstract]
Restructuring Charges	6,400
Restructuring
Restructuring Charges	6,400
fiscal year 2023 initiative [Member]
Restructuring and Related Activities [Abstract]
Restructuring Charges			2,871		34,025
Restructuring and Related Cost, Incurred Cost				$ 599
Restructuring
Restructuring Charges			2,871		34,025
Payments for Restructuring				(10,162)
Restructuring Reserve	92			92		$ 92	$ 92	$ 9,655
Restructuring and Related Cost, Incurred Cost				599
fiscal year 2023 initiative [Member] | One-time Employee Termination Benefits
Restructuring and Related Activities [Abstract]
Restructuring Charges			7		2,681		5,900
Restructuring and Related Cost, Incurred Cost				321
Restructuring
Restructuring Charges			7		2,681		5,900
Payments for Restructuring				(668)
Restructuring Reserve	0			0		0	0	347
Restructuring and Related Cost, Incurred Cost				321
fiscal year 2023 initiative [Member] | impairment charges
Restructuring and Related Activities [Abstract]
Restructuring Charges			2,341		8,786		99,900
Restructuring
Restructuring Charges			2,341		8,786		99,900
fiscal year 2023 initiative [Member] | Lease and other contract terminations
Restructuring and Related Activities [Abstract]
Restructuring Charges			523		22,558		46,300
Restructuring and Related Cost, Incurred Cost				278
Restructuring
Restructuring Charges			523		22,558		46,300
Payments for Restructuring				(9,494)
Restructuring Reserve	92			92		92	92	9,308
Restructuring and Related Cost, Incurred Cost				278
fiscal year 2023 initiative [Member] | Impaired goodwill
Restructuring and Related Activities [Abstract]
Restructuring Charges							12,400
Restructuring
Restructuring Charges							12,400
Fiscal year 2024 initiative [Member]
Restructuring and Related Activities [Abstract]
Restructuring Charges	567			17,746
Restructuring and Related Cost, Incurred Cost				10,274
Restructuring
Restructuring Charges	567			17,746
Payments for Restructuring				(20,587)
Restructuring Reserve	1,199			1,199		1,199	1,199	11,512
Restructuring and Related Cost, Incurred Cost				10,274
Fiscal year 2024 initiative [Member] | One-time Employee Termination Benefits
Restructuring and Related Activities [Abstract]
Restructuring Charges	386			6,098		15,000
Restructuring and Related Cost, Incurred Cost				6,098
Restructuring
Restructuring Charges	386			6,098		15,000
Payments for Restructuring				(12,512)
Restructuring Reserve	1,018			1,018		1,018	1,018	7,432
Restructuring and Related Cost, Incurred Cost				6,098
Fiscal year 2024 initiative [Member] | impairment charges
Restructuring and Related Activities [Abstract]
Restructuring Charges	0			7,472		44,400
Restructuring
Restructuring Charges	0			7,472		44,400
Fiscal year 2024 initiative [Member] | Lease and other contract terminations
Restructuring and Related Activities [Abstract]
Restructuring Charges	181			4,176		11,400
Restructuring and Related Cost, Incurred Cost				4,176
Restructuring
Restructuring Charges	181			4,176		11,400
Payments for Restructuring				(8,075)
Restructuring Reserve	181			181		181	181	4,080
Restructuring and Related Cost, Incurred Cost				4,176
Fiscal year 2025 initiative
Restructuring and Related Activities [Abstract]
Restructuring Charges	67,393			197,325
Restructuring and Related Cost, Incurred Cost				47,692
Restructuring
Restructuring Charges	67,393			197,325
Payments for Restructuring				(9,715)
Restructuring Reserve	37,977			37,977		37,977	37,977	0
Restructuring and Related Cost, Incurred Cost				47,692
Impairment of Intangible Assets, Finite-Lived		16,600
Fiscal year 2025 initiative | One-time Employee Termination Benefits
Restructuring and Related Activities [Abstract]
Restructuring Charges	6,639			6,639
Restructuring and Related Cost, Incurred Cost				6,639
Restructuring
Restructuring Charges	6,639			6,639
Payments for Restructuring				(302)
Restructuring Reserve	6,337			6,337		6,337	6,337	0
Restructuring and Related Cost, Incurred Cost				6,639
Fiscal year 2025 initiative | impairment charges
Restructuring and Related Activities [Abstract]
Restructuring Charges	16,518			143,402
Restructuring
Restructuring Charges	16,518			143,402
Fiscal year 2025 initiative | Lease and other contract terminations
Restructuring and Related Activities [Abstract]
Restructuring Charges	44,236			47,284
Restructuring and Related Cost, Incurred Cost				41,053
Restructuring
Restructuring Charges	44,236			47,284
Payments for Restructuring				(9,413)
Restructuring Reserve	31,640			31,640		$ 31,640	$ 31,640	$ 0
Restructuring and Related Cost, Incurred Cost				41,053
Other operating expense | fiscal year 2023 initiative [Member]
Restructuring and Related Activities [Abstract]
Restructuring Charges			3,121		12,838
Restructuring
Restructuring Charges			3,121		12,838
Other operating expense | fiscal year 2023 initiative [Member] | One-time Employee Termination Benefits
Restructuring and Related Activities [Abstract]
Restructuring Charges			7		2,681
Restructuring
Restructuring Charges			7		2,681
Other operating expense | fiscal year 2023 initiative [Member] | impairment charges
Restructuring and Related Activities [Abstract]
Restructuring Charges			2,341		6,627
Restructuring
Restructuring Charges			2,341		6,627
Other operating expense | fiscal year 2023 initiative [Member] | Lease and other contract terminations
Restructuring and Related Activities [Abstract]
Restructuring Charges			773		3,530
Restructuring
Restructuring Charges			773		3,530
Other operating expense | Fiscal year 2024 initiative [Member]
Restructuring and Related Activities [Abstract]
Restructuring Charges	$ 567			$ 15,992
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]	Operating Expenses			Operating Expenses
Restructuring
Restructuring Charges	$ 567			$ 15,992
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]	Operating Expenses			Operating Expenses
Other operating expense | Fiscal year 2024 initiative [Member] | One-time Employee Termination Benefits
Restructuring and Related Activities [Abstract]
Restructuring Charges	$ 386			$ 6,098
Restructuring
Restructuring Charges	386			6,098
Other operating expense | Fiscal year 2024 initiative [Member] | impairment charges
Restructuring and Related Activities [Abstract]
Restructuring Charges	0			5,718
Restructuring
Restructuring Charges	0			5,718
Other operating expense | Fiscal year 2024 initiative [Member] | Lease and other contract terminations
Restructuring and Related Activities [Abstract]
Restructuring Charges	181			4,176
Restructuring
Restructuring Charges	181			4,176
Other operating expense | Fiscal year 2025 initiative
Restructuring and Related Activities [Abstract]
Restructuring Charges	60,463			80,277
Restructuring
Restructuring Charges	60,463			80,277
Other operating expense | Fiscal year 2025 initiative | One-time Employee Termination Benefits
Restructuring and Related Activities [Abstract]
Restructuring Charges	6,639			6,639
Restructuring
Restructuring Charges	6,639			6,639
Other operating expense | Fiscal year 2025 initiative | impairment charges
Restructuring and Related Activities [Abstract]
Restructuring Charges	15,819			32,585
Restructuring
Restructuring Charges	15,819			32,585
Other operating expense | Fiscal year 2025 initiative | Lease and other contract terminations
Restructuring and Related Activities [Abstract]
Restructuring Charges	38,005			41,053
Restructuring
Restructuring Charges	38,005			41,053
Cost of goods sold | fiscal year 2023 initiative [Member]
Restructuring and Related Activities [Abstract]
Restructuring Charges			(250)		21,187
Restructuring
Restructuring Charges			(250)		21,187
Cost of goods sold | fiscal year 2023 initiative [Member] | One-time Employee Termination Benefits
Restructuring and Related Activities [Abstract]
Restructuring Charges			0		0
Restructuring
Restructuring Charges			0		0
Cost of goods sold | fiscal year 2023 initiative [Member] | impairment charges
Restructuring and Related Activities [Abstract]
Restructuring Charges			0		2,159
Restructuring
Restructuring Charges			0		2,159
Cost of goods sold | fiscal year 2023 initiative [Member] | Lease and other contract terminations
Restructuring and Related Activities [Abstract]
Restructuring Charges			(250)		19,028
Restructuring
Restructuring Charges			$ (250)		$ 19,028
Cost of goods sold | Fiscal year 2024 initiative [Member]
Restructuring and Related Activities [Abstract]
Restructuring Charges	$ 0			$ 1,754
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]	Operating Expenses			Cost of goods sold
Restructuring
Restructuring Charges	$ 0			$ 1,754
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]	Operating Expenses			Cost of goods sold
Cost of goods sold | Fiscal year 2024 initiative [Member] | One-time Employee Termination Benefits
Restructuring and Related Activities [Abstract]
Restructuring Charges	$ 0			$ 0
Restructuring
Restructuring Charges	0			0
Cost of goods sold | Fiscal year 2024 initiative [Member] | impairment charges
Restructuring and Related Activities [Abstract]
Restructuring Charges	0			1,754
Restructuring
Restructuring Charges	0			1,754
Cost of goods sold | Fiscal year 2024 initiative [Member] | Lease and other contract terminations
Restructuring and Related Activities [Abstract]
Restructuring Charges	0			0
Restructuring
Restructuring Charges	0			0
Cost of goods sold | Fiscal year 2025 initiative
Restructuring and Related Activities [Abstract]
Restructuring Charges	6,930			20,590
Restructuring
Restructuring Charges	6,930			20,590
Cost of goods sold | Fiscal year 2025 initiative | One-time Employee Termination Benefits
Restructuring and Related Activities [Abstract]
Restructuring Charges	0			0
Restructuring
Restructuring Charges	0			0
Cost of goods sold | Fiscal year 2025 initiative | impairment charges
Restructuring and Related Activities [Abstract]
Restructuring Charges	699	13,700		14,359
Restructuring
Restructuring Charges	699	13,700		14,359
Cost of goods sold | Fiscal year 2025 initiative | Lease and other contract terminations
Restructuring and Related Activities [Abstract]
Restructuring Charges	6,231			6,231
Restructuring
Restructuring Charges	6,231			6,231
Impaired goodwill | Fiscal year 2025 initiative
Restructuring and Related Activities [Abstract]
Restructuring Charges	0			96,458
Restructuring
Restructuring Charges	0			96,458
Impaired goodwill | Fiscal year 2025 initiative | One-time Employee Termination Benefits
Restructuring and Related Activities [Abstract]
Restructuring Charges	0			0
Restructuring
Restructuring Charges	0			0
Impaired goodwill | Fiscal year 2025 initiative | impairment charges
Restructuring and Related Activities [Abstract]
Restructuring Charges	0	96,500		96,458
Restructuring
Restructuring Charges	0	$ 96,500		96,458
Impaired goodwill | Fiscal year 2025 initiative | Lease and other contract terminations
Restructuring and Related Activities [Abstract]
Restructuring Charges	0			0
Restructuring
Restructuring Charges	$ 0			$ 0

Operating Segment Information_2

Operating Segment Information (Details) $ in Thousands	3 Months Ended			9 Months Ended
	Dec. 28, 2024 USD ($)	Sep. 28, 2024 USD ($)	Dec. 30, 2023 USD ($)	Dec. 28, 2024 USD ($)	Dec. 30, 2023 USD ($)
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Document Period End Date				Dec. 28, 2024
Summary of details of reportable segments
Revenues	$ 916,317		$ 1,073,861	$ 2,849,497	$ 2,828,518
Income from operations:
Operating income (loss)	53,025		(41,569)	67,306	61,723
Interest expense	18,655		17,581	58,343	51,963
Other income (expense), net	14,526		15,359	41,713	34,286
Income (loss) before income taxes	48,896		(43,791)	50,676	44,046
Stock-based compensation expense				(108,931)	(99,253)
Amortization of intangible assets				(103,146)	(92,308)
Goodwill, Impairment Loss	$ 0	$ (96,500)	(173,414)	(96,458)	(221,414)
Number of Reportable Segments	3
HPA
Income from operations:
Goodwill, Impairment Loss				(96,458)
CSG
Income from operations:
Goodwill, Impairment Loss				0
ACG
Income from operations:
Goodwill, Impairment Loss				0
Operating Segments | HPA
Summary of details of reportable segments
Revenues	$ 171,678		118,890	449,397	408,386
Income from operations:
Operating income (loss)	32,580		1,578	50,527	50,988
Operating Segments | CSG
Summary of details of reportable segments
Revenues	109,567		108,898	371,242	311,783
Income from operations:
Operating income (loss)	(11,736)		(25,590)	(40,211)	(73,476)
Operating Segments | ACG
Summary of details of reportable segments
Revenues	635,072		846,073	2,028,858	2,108,349
Income from operations:
Operating income (loss)	161,228		263,792	492,734	593,595
All other
Income from operations:
Operating income (loss)	(129,047)		(281,349)	(435,744)	(509,384)
Stock-based compensation expense	(28,384)		(21,755)	(108,931)	(99,253)
Amortization of intangible assets	(26,085)		(29,787)	(86,041)	(90,622)
Restructuring Charges	(68,072)		(6,075)	(122,042)	(37,229)
Acquisition and integration-related costs	(1,382)		(2,529)	(5,175)	(4,576)
Other	(6,377)		4,075	(21,821)	(4,426)
Capitalized Contract Cost, Impairment Loss	$ 1,253		$ (51,864)	$ 4,724	$ (51,864)

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 28, 2024	Dec. 30, 2023	Dec. 28, 2024	Dec. 30, 2023
Income Tax Disclosure [Abstract]
Income tax benefit	$ 7,625	$ 83,147	$ 26,426	$ 117,103
Effective tax rate	15.60%	(189.90%)	52.10%	265.90%
Effective Income Tax Rate Reconciliation, Disposition of Business, Amount	$ 11,400		$ 11,200
Effective Income Tax Rate Reconciliation, Foreign Currency Gain or Loss				$ 45,700
Effective Income Tax Rate Reconciliation, Tax Settlement, Other, Amount		$ 40,200

Net Income Per Share (Details)

Net Income Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 28, 2024	Dec. 30, 2023	Dec. 28, 2024	Dec. 30, 2023
Earnings Per Share [Abstract]
Document Period End Date			Dec. 28, 2024
Numerator:
Numerator for basic and diluted net income (loss) per share — net income (loss) available to common stockholders	$ 41,271	$ (126,938)	$ 24,250	$ (73,057)
EPS Line Items
Denominator for basic net income (loss) per share — weighted average shares	94,341	97,152	94,942	97,905
Stock-based awards	690	0	866	0
Denominator for diluted net income (loss) per share — adjusted weighted average shares and assumed conversions	95,031	97,152	95,808	97,905
Basic net income (loss) per share (in dollars per share)	$ 0.44	$ (1.31)	$ 0.26	$ (0.75)
Diluted net income (loss) per share (in dollars per share)	$ 0.43	$ (1.31)	$ 0.25	$ (0.75)
Antidilutive shares excluded from the computation of diluted shares outstanding	2,000	2,200	800	1,600